[go: up one dir, main page]

MX2010010597A - Processes for the preparation of benzo-fused dioxin derivatives. - Google Patents

Processes for the preparation of benzo-fused dioxin derivatives.

Info

Publication number
MX2010010597A
MX2010010597A MX2010010597A MX2010010597A MX2010010597A MX 2010010597 A MX2010010597 A MX 2010010597A MX 2010010597 A MX2010010597 A MX 2010010597A MX 2010010597 A MX2010010597 A MX 2010010597A MX 2010010597 A MX2010010597 A MX 2010010597A
Authority
MX
Mexico
Prior art keywords
benzo
processes
preparation
fused
dioxin derivatives
Prior art date
Application number
MX2010010597A
Other languages
Spanish (es)
Inventor
Scott A Ballentine
Laura Reany
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX2010010597A publication Critical patent/MX2010010597A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention is directed to processes for the preparation of benzo-fused heteroaryl derivatives, useful for the treatment of epilepsy and related disorders. The present invention is further directed to processes for the preparation of intermediates in the synthesis of the benzo-fused heteroaryl derivatives.
MX2010010597A 2008-03-26 2008-03-26 Processes for the preparation of benzo-fused dioxin derivatives. MX2010010597A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/058247 WO2009120192A2 (en) 2008-03-26 2008-03-26 Process for the preparation of benzo-fused heteroaryl derivatives

Publications (1)

Publication Number Publication Date
MX2010010597A true MX2010010597A (en) 2010-10-25

Family

ID=40351717

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010010597A MX2010010597A (en) 2008-03-26 2008-03-26 Processes for the preparation of benzo-fused dioxin derivatives.

Country Status (13)

Country Link
EP (1) EP2280951A2 (en)
JP (1) JP2011517448A (en)
KR (1) KR20100126536A (en)
CN (1) CN101981023A (en)
AU (1) AU2008353492A1 (en)
BR (1) BRPI0822396A2 (en)
CA (1) CA2719402A1 (en)
EA (1) EA201071121A1 (en)
EC (1) ECSP10010498A (en)
IL (1) IL208223A0 (en)
MX (1) MX2010010597A (en)
WO (1) WO2009120192A2 (en)
ZA (1) ZA201007610B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
EP1881959A1 (en) 2005-05-20 2008-01-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
AU2007253814A1 (en) 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
WO2010008776A2 (en) * 2008-06-23 2010-01-21 Janssen Pharmaceutica Nv Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
KR20140082736A (en) * 2011-09-29 2014-07-02 얀센 파마슈티카 엔.브이. Process for the preparation of sulfamide derivatives
KR20140082762A (en) * 2011-09-29 2014-07-02 얀센 파마슈티카 엔.브이. Improved process for the preparation of sulfamide derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120758A (en) * 1991-02-08 1992-06-09 Ciba-Geigy Corporation Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders

Also Published As

Publication number Publication date
WO2009120192A2 (en) 2009-10-01
KR20100126536A (en) 2010-12-01
JP2011517448A (en) 2011-06-09
IL208223A0 (en) 2010-12-30
CA2719402A1 (en) 2009-10-01
WO2009120192A3 (en) 2010-01-21
ECSP10010498A (en) 2010-10-30
BRPI0822396A2 (en) 2019-09-24
CN101981023A (en) 2011-02-23
EP2280951A2 (en) 2011-02-09
ZA201007610B (en) 2012-04-25
AU2008353492A1 (en) 2009-10-01
EA201071121A1 (en) 2011-04-29

Similar Documents

Publication Publication Date Title
MX2010010597A (en) Processes for the preparation of benzo-fused dioxin derivatives.
MX2010007490A (en) Preparation of sulfamide derivatives.
MX2011009369A (en) Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators.
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
UA102251C2 (en) Aminidihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
MX2020012825A (en) Multicyclic compounds and methods of use thereof.
TN2012000578A1 (en) Tetrahydro-pyrido-pyrimidine derivatives
MX2011009539A (en) Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof.
IL211541A0 (en) Co-crystal compositions, methods of producing the same and uses thereof
UA86731C2 (en) Divisible galenic form of the modified drug release
IN2012DN03182A (en)
MX2011008825A (en) Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators.
WO2010009879A3 (en) Methods for producing paricalcitol
EA201101194A1 (en) APPLICATION OF ROSUVASTATIN LACTOL AS A MEDICINE PREPARATION
JO2682B1 (en) 7-ALkynyl-1,8-Naphthyridone Derivatives, Preparation Thereof And Therapeutic Use Thereof
MX2011008662A (en) Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators.
MX2011009338A (en) Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators.
MY146671A (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
UA106724C2 (en) Process for preparation of substituted pyrimidine derivatives
MX2012007142A (en) Use of 2,3-dihydroxypropyl dodecanoate for treating seborrhea.
MY156873A (en) Novel forms of a multicyclic compound
PH12017500270A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
MX2013006670A (en) 2-carboxamide-4-piperazinyl-benzofuran derivative.
WO2010107897A3 (en) Process for the preparation of histamine h3 receptor modulators
MX2010003056A (en) Valomaciclovir polymorphs.